From the Journals

Yale-Brown Obsessive Scale shows value for assessing binge eating patients


 

FROM QUALITY OF LIFE RESEARCH

Symptoms of binge eating disorder can be assessed with a modified version of the Yale-Brown Obsessive Compulsive Scale, based on data from an analysis of three phase III studies.

The Yale-Brown Obsessive Compulsive Scale Modified for Binge Eating (Y-BOCS-BE) is designed to assess symptoms of binge eating disorder (BED), including binge eating thoughts and compulsiveness. “Psychometric testing and analysis of the Y-BOCS-BE is being conducted as a multistage process to optimize the characterization of BED,” wrote Karen Yee, PhD, of Shire (now part of Takeda), Boston, and colleagues.

In a study published in Quality of Life Research, investigators examined the validity of the Y-BOCS-BE in terms of dimensionality, internal consistency, convergent validity, test-retest reliability, and determination of clinically meaningful improvement. The Y-BOCS-BE is a 10-item clinician-rated scale with total scores from 0 to 4 on which 0 equals no symptoms and 4 equals extreme symptoms.

Overall, the Y-BOCS-BE’s internal consistency and convergent validity were maximized at 12 weeks, and test-retest reliability was maximized in an 8-week retest interval, minimal clinically important improvement could not be assessed in the two short-term efficacy studies, but “estimates in score reductions of 12-17 points were taken to represent the best estimates of clinically meaningful improvement,” the researchers said.

The findings were limited by several factors including the use of a study population of BED patients without psychiatric comorbidities, and the inclusion only of those who did not relapse the researchers noted. However, the results “set the stage for normalizing the Y-BOCS-BE and increasing the understanding of the clinical significance of Y-BOCS-BE scores and score changes to be useful both for clinical practice and clinical research,” they said.

Dr. Yee disclosed being employed by Shire and owning stock in Takeda. The studies were funded by Shire.

SOURCE: Yee K et al. Qual Life Res. 2019 Aug 31. doi: 10.1007/s11136-019-02277-8 .

Recommended Reading

Tryptophan depletion may explain high rate of eating disorders in women
MDedge Psychiatry
Eating disorders put teens at risk for depression, bullying
MDedge Psychiatry
MDedge Daily News: Where doctors stand on Medicaid work requirements
MDedge Psychiatry
VIDEO: Move beyond BMI to see obesity as a disease
MDedge Psychiatry
How to handle anorexia in community hospitals
MDedge Psychiatry
Interacting with horses helps veterans with PTSD; Identical twin battles anorexia
MDedge Psychiatry
Bariatric surgery ups risk of suicide, self-harm
MDedge Psychiatry
Family estrangement: Would mutual respect make a difference?
MDedge Psychiatry
FDA accepts dasotraline NDA for binge-eating disorder
MDedge Psychiatry
Study: Half of college women exhibited binge eating symptoms
MDedge Psychiatry